Re: Moab to CD40L
ResearchD@aol.com
Thu, 10 Oct 1996 22:55:02 -0400
Interestingly, Biogen Inc (Cambridge MA) claims to own the patent rights to
all antibodies against CD40L (see patent # 5,474,771), licensed from Columbia
University for their developed clone#5C8). They have served notice of
potential infringement to various vendors so you may want to get your
antibody soon!
By the way, is anyone aware of a similar claim by Becton Dickinson for CD34
which I thought was overturned by a higher level patent court? If not, then
any patents on one clone could begin to expand to make all other clones
infringers. This will dimish choice and/or make these natibodies even more
expensive if numerous licenses are needed! Welcome to the world pf biotech
patents.!
Sincerely,
Research Diagnostics Inc
email:ResearchD@aol.com
web: http://www.researchd.com
CD ROM Vol 2 was produced by staff at the Purdue University Cytometry Laboratories
and distributed free of charge as an educational service to the cytometry community.
If you have any comments please direct them to Dr. J. Paul Robinson, Professor & Director, PUCL,
Purdue University, West Lafayette, IN 47907. Phone:(317) 494-0757; FAX (317) 494-0517; Web http://www.cyto.purdue.edu
EMAIL robinson@flowcyt.cyto.purdue.edu
